DXCM DexCom, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

DXCM [NASD]

DexCom, Inc.

Healthcare | Diagnostics & Research | USA

statements

Index	S&P 500	P/E	276.16	EPS (ttm)	1.59	Insider Own	0.80%	Shs Outstand	91.80M	Perf Week	7.93%
Market Cap	41.54B	Forward P/E	145.87	EPS next Y	3.01	Insider Trans	-23.12%	Shs Float	91.70M	Perf Month	14.14%
Income	147.90M	PEG	5.32	EPS next Q	0.35	Inst Own	99.60%	Short Float	4.29%	Perf Quarter	59.71%
Sales	1.60B	P/S	25.95	EPS this Y	175.80%	Inst Trans	1.56%	Short Ratio	2.17	Perf Half Y	83.74%
Book/sh	10.18	P/B	43.19	EPS next Y	31.33%	ROA	6.50%	Target Price	400.47	Perf Year	188.29%
Cash/sh	15.99	P/C	27.50	EPS next 5Y	51.95%	ROE	18.10%	52W Range	138.28 - 445.52	Perf YTD	100.99%
Dividend	-	P/FCF	317.81	EPS past 5Y	41.50%	ROI	7.10%	52W High	-7.86%	Beta	0.78
Dividend %	-	Quick Ratio	5.40	Sales past 5Y	41.60%	Gross Margin	64.80%	52W Low	196.86%	ATR	17.88
Employees	3900	Current Ratio	5.80	Sales Q/Q	44.40%	Oper. Margin	11.90%	RSI (14)	50.86	Volatility	3.58% 4.53%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	171.00%	Profit Margin	9.20%	Rel Volume	0.69	Prev Close	439.64
Shortable	Yes	LT Debt/Eq	1.16	Earnings	Jul 28 AMC	Payout	0.00%	Avg Volume	1.81M	Price	410.50
Recom	1.60	SMA20	0.85%	SMA50	4.71%	SMA200	52.92%	Volume	1,153,919	Change	-6.63%

May-27-20

Reiterated

Piper Sandler

Overweight

$375 → $450

May-14-20

Initiated

Wells Fargo

Equal Weight

$420

Mar-05-20

Initiated

Citigroup

Buy

$330

Nov-07-19

Upgrade

Guggenheim

Neutral → Buy

Nov-07-19

Reiterated

Canaccord Genuity

Buy

$185 → $195

Oct-23-19

Initiated

Stifel

Buy

Nov-28-18

Initiated

UBS

Neutral

$135

Oct-19-18

Upgrade

Goldman

Sell → Neutral

Sep-12-18

Upgrade

Northland Capital

Under Perform → Market Perform

Aug-02-18

Reiterated

Canaccord Genuity

Buy

$105 → $125

Jul-02-18

Upgrade

Raymond James

Mkt Perform → Outperform

Jun-08-18

Upgrade

JP Morgan

Neutral → Overweight

May-11-18

Initiated

BofA/Merrill

Buy

$100

May-03-18

Reiterated

Canaccord Genuity

Buy

$81 → $85

Apr-04-18

Initiated

Guggenheim

Neutral

Apr-04-18

Initiated

Goldman

Sell

$57

Mar-23-18

Upgrade

Robert W. Baird

Neutral → Outperform

Jan-04-18

Downgrade

Northland Capital

Market Perform → Under Perform

Sep-28-17

Reiterated

Wedbush

Outperform

$85 → $76

Sep-28-17

Downgrade

Raymond James

Outperform → Mkt Perform

Jul-10-20 05:45PM	DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know Zacks
Jul-08-20 03:21PM	Were Hedge Funds Right About Piling Into DexCom, Inc. (DXCM)? Insider Monkey
Jul-07-20 08:11AM	Dow Jones Futures Fall After Apple, Amazon, Tesla, Microsoft Lead Coronavirus Stock Market Rally; Alibaba, Dexcom, Chipotle Break Out Investor's Business Daily
Jul-06-20 11:17AM	Dexcom Clears Buy Point Investor's Business Daily Video
08:48AM	The 3 Best S&P 500 Stocks So Far in 2020 Motley Fool
Jul-01-20 03:15PM	Dow Jones' Strength Wavers Due To Recent Rise In Coronavirus Cases; Growth Stocks Lead Market Investor's Business Daily
12:10PM	Will DexCom (DXCM) Beat Estimates Again in Its Next Earnings Report? Zacks
07:28AM	If You Invested $1,000 in Dexcom's IPO, This Is How Much Money You'd Have Now Motley Fool
Jun-30-20 05:50PM	DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know Zacks
03:13PM	Top Stocks for July 2020 Investopedia
08:45AM	Dexcom Schedules Second Quarter 2020 Earnings Release and Conference Call for July 28, 2020 at 4:30 p.m. Eastern Time Business Wire
Jun-26-20 08:23AM	Dow Jones Futures: Coronavirus Stock Market Rally Resilient As Tesla Leads Bullish Rebounds; Nike, JPMorgan, Goldman Move Late Investor's Business Daily
Jun-25-20 01:44PM	Top Health Care Stocks for July 2020 Investopedia
Jun-24-20 06:00AM	How This Bond Fund Has Beaten the Stock Market Over 25 Years Barrons.com
Jun-19-20 11:55AM	The Zacks Analyst Blog Highlights: Tesla, Fortinet, West Pharmaceutical Services, DexCom and Tractor Supply Zacks
Jun-18-20 07:43AM	Here's Why You Should Retain Glaukos in Your Portfolio Now Zacks
07:21AM	5 Best Stocks From 100 Days of Coronavirus Zacks
Jun-17-20 11:09AM	The Zacks Analyst Blog Highlights: Reckitt Benckiser, Henkel AG, DexCom, Tencent and Peloton Interactive Zacks
07:11AM	3 MedTech Stocks to Watch Amid Coronavirus Catastrophe Zacks
Jun-16-20 05:50PM	DexCom (DXCM) Stock Sinks As Market Gains: What You Should Know Zacks
08:10AM	Dow Jones Futures Jump, Extending Coronavirus Stock Market Rally; Tesla Back Above 1,000 Investor's Business Daily
Jun-15-20 05:18PM	Abbott Gains FDA Nod For A New Diabetes Device, But Dexcom Rockets Investor's Business Daily +7.70%
03:46PM	IBD 50 Stocks To Watch: Top Growth Stock Dexcom Surges After Key Hold Rule Expires Investor's Business Daily
10:35AM	Dexcom Keeps Finding Support Investor's Business Daily Video
10:25AM	Abbott's Bluetooth-Enabled Glucose Monitor Finally Clears FDA Hurdle Motley Fool
Jun-12-20 08:58AM	3 Diabetes Management Stocks in the Spotlight Amid Coronavirus Zacks
Jun-10-20 06:59PM	Top-Performing Nasdaq Stocks So Far in 2020 GuruFocus.com
05:50PM	DexCom (DXCM) Gains As Market Dips: What You Should Know Zacks
08:19AM	DexCom's (DXCM) G6 CGM System Gets CE Marking in Europe Zacks
Jun-09-20 04:00AM	Dexcom G6 Continuous Glucose Monitoring (CGM) System Receives CE Marking in Europe for Wear on Back of the Upper Arm PR Newswire
Jun-08-20 04:33PM	IBD Stock Of The Day Dexcom Rebounds Into A New Buy Zone Here's Why Investor's Business Daily
09:32AM	ABIOMED Gets FDA Nod for First-in-Human Trial of Impella ECP Zacks
Jun-06-20 08:31AM	Here are the 10 most under and overbought S&P 500 stocks, according to Goldman MarketWatch
Jun-05-20 03:40PM	Dow Jones Soars 1,955 Points In 5 Days, Oil Jumps 5%; These 5 Top Stocks Break Out Investor's Business Daily +5.70%
10:42AM	Dexcom Rebounds Investor's Business Daily Video
09:48AM	Here's Why You Should Retain AmerisourceBergen Stock Now Zacks
08:15AM	Dow Jones Futures Lead Coronavirus Market Rally With Jobs Report In Focus; Tesla Back In 'Friend Zone,' Slack, RH Lead Earnings Movers Investor's Business Daily
Jun-04-20 05:00PM	Dow Jones Holds Up Better Than Nasdaq, Boeing Rockets Again; Sell Dexcom, Or Buy More? Investor's Business Daily -5.74%
09:00AM	Dexcom Announces Upcoming Conference Presentation Business Wire
Jun-03-20 03:13PM	Top Performers in the S&P 500 This Year Investopedia
09:35AM	ABIOMED's (ABMD) Impella RP Receives FDA's EUA Clearance Zacks
Jun-02-20 08:00AM	Here Are The 12 Places Real Money Is Made In June Investor's Business Daily
Jun-01-20 09:50AM	Here's Why You Should Add DexCom (DXCM) to Your Portfolio Zacks
May-28-20 11:31AM	DexCom (DXCM) Up 4.1% Since Last Earnings Report: Can It Continue? Zacks
09:41AM	Picking a Long/Short Fund Isnt Easy, But It Can Be Profitable. Heres How. Barrons.com
May-27-20 09:47AM	Varian (VAR) Unveils New Features for Noona Software Zacks -5.80%
09:37AM	DexCom (DXCM) Stock Remains Resilient to Virus Slump Insider Monkey
09:34AM	5 Health Care Stocks to Bet on as Coronavirus Woes Linger Zacks
May-26-20 07:55PM	Hedge Funds Have Never Been This Bullish On DexCom, Inc. (DXCM) Insider Monkey -5.79%
01:38PM	Frank Sands Adds 5 Stocks to Portfolio GuruFocus.com
08:51AM	Here's Why You Should Add Surmodics to Your Portfolio Now Zacks
May-22-20 08:02PM	How to Protect Your Portfolio With and From Liquid Alts Barrons.com
May-20-20 10:47AM	Surging Diabetes Market Lifts Dexcom Into Top Spot in S&P 500 Bloomberg
04:15AM	Here's Why You Should Retain Merit Medical (MMSI) for Now Zacks
May-19-20 10:26AM	Allscripts Unit Inks Deal to Boost Veradigm AccelRx Platform Zacks
May-18-20 12:48PM	Edited Transcript of DXCM earnings conference call or presentation 28-Apr-20 8:30pm GMT Thomson Reuters StreetEvents
11:30AM	Is DexCom (DXCM) Outperforming Other Medical Stocks This Year? Zacks
May-16-20 12:51PM	12 health-care stocks that will be winners because of coronavirus-led trends, according to Jefferies MarketWatch
06:44AM	DexCom and Dominos Pizza Join the S&P 500. Should You Buy? Motley Fool
May-15-20 11:20AM	Nasdaq ETF (QQQ) Joins $100 Billion Club: 10 Stock Winners Zacks
08:00AM	Better Than Bezos? Three Stocks Keep Beating Amazon Investor's Business Daily
May-12-20 03:56PM	[video]DexCom Stock Has Been Soaring: Here's What Could Happen Next TheStreet.com
08:36AM	ESG Stocks Remain Resilient to Virus Slump: 5 Top Picks Zacks
07:00AM	DexCom Prices Offering of Upsized $1.05 Billion of 0.25% Convertible Senior Notes Business Wire
May-11-20 11:47AM	IBD Live Q&A And Two Key Stock Lists For May 11, 2020 Investor's Business Daily
11:25AM	3 Stocks Growing Capex Fast GuruFocus.com
09:49AM	Why DexCom Stock Rocketed Higher in April Motley Fool
07:00AM	DexCom Announces Proposed Offering of $850.0 Million of Convertible Senior Notes Business Wire
May-09-20 02:19PM	The Nasdaq is now up for the year here are the indexs best-performing stocks MarketWatch
May-08-20 05:52PM	DexCom, Inc. Announces Change of Location of Annual Meeting of Stockholders to Be Held May 21, 2020 Business Wire
09:58AM	Is DexCom (DXCM) Stock a Smart Long-Term Buy? Insider Monkey
05:45AM	Coronavirus Pandemic Propels User Growth for Livongo Health Motley Fool
May-06-20 07:23PM	DexCom & Domino's Pizza Set to Join S&P 500; Salesforce.com to Join S&P 100; STORE Capital to Join S&P MidCap 400; Capri Holdings to Join S&P SmallCap 600 PR Newswire
06:11PM	Domino's Pizza to join S&P 500, despite pandemic's impact Reuters
06:08PM	Domino's Pizza, DexCom to join S&P 500 MarketWatch
May-05-20 12:41PM	Heres Why Baron Asset Fund Likes DexCom (DXCM) Stock Insider Monkey
May-04-20 11:06AM	RiverPark Advisors is Bullish on Bill.com (BILL) and DexCom (DXCM) stocks Insider Monkey
08:30AM	Health Canada Temporarily Authorizes Dexcom G6 CGM for Use in Hospitals to Monitor Critically Ill Patients During COVID-19 Pandemic CNW Group
May-01-20 11:30AM	Is DexCom (DXCM) Stock Outpacing Its Medical Peers This Year? Zacks
10:22AM	3 "Non-Coronavirus Stocks" That Would Have Doubled Your Money Over the Last Year Motley Fool
Apr-29-20 04:39PM	Dexcom CEO Sees A Burgeoning Opportunity Amid Coronavirus Pandemic Investor's Business Daily +10.19%
11:13AM	DexCom (DXCM) Q1 Earnings and Revenues Surpass Estimates Zacks
07:00AM	How DexCom's Q1 Results Trounced Wall Street Expectations Motley Fool
02:31AM	DexCom (DXCM) Q1 2020 Earnings Call Transcript Motley Fool
Apr-28-20 05:15PM	DexCom (DXCM) Tops Q1 Earnings and Revenue Estimates Zacks -6.42%
04:03PM	Dexcom Reports First Quarter 2020 Financial Results Business Wire
07:31AM	How Good Is DexCom, Inc. (NASDAQ:DXCM), When It Comes To ROE? Simply Wall St.
Apr-27-20 09:45AM	Why DexCom (DXCM) Might Surprise This Earnings Season Zacks
08:28AM	AMN Healthcare Inks Deal to Address Healthcare System Needs Zacks
08:00AM	Dexcom to Launch Patient Assistance Program for Current U.S. Customers Impacted by COVID-19 Pandemic Business Wire
Apr-24-20 09:59AM	ABIOMED (ABMD) to Report Q4 Earnings: What's in the Cards? Zacks
09:05AM	3 Medical Product Stocks Set to Beat This Earnings Season Zacks
Apr-23-20 06:54AM	DexCom (DXCM) to Report Q1 Earnings: What's in the Offing? Zacks
Apr-22-20 04:18PM	Breakout Watch: 52 A+ Funds Inject New Life Into This Medical Supplies Stock Investor's Business Daily
11:09AM	The Zacks Analyst Blog Highlights: Eli Lilly, DexCom, ViewRay, Chemed and Sage Therapeutics Zacks
Apr-21-20 07:39AM	Buy 5 Top Health Care Stocks Ahead of Q1 Earnings Results Zacks
07:22AM	Pacific Biosciences' Sequel II Gets Acquired by inqaba biotec Zacks
Apr-20-20 09:09AM	DexCom (DXCM) Jumps: Stock Rises 5.6% Zacks
08:27AM	Here's Why You Should Retain Accuray in Your Portfolio Zacks
Apr-17-20 09:12AM	3 MedTech Stocks Likely to Have Braved Coronavirus Blow in Q1 Zacks +5.59%

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, a CGM system for diabetes management; DexCom G5 mobile CGM system to communicate directly to patient's mobile device; DexCom G4 PLATINUM system for continuous use by adults with diabetes; and DexCom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop a series of next-generation CGM products; and a collaboration with Companion Medical, Inc. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Murphy Patrick Michael	EVP, Chief Legal Officer	Jul 09	Sale	435.80	500	217,900	28,676	Jul 10 05:13 PM
SAYER KEVIN R	President, CEO and Chairman	Jul 06	Sale	420.94	6,000	2,525,662	152,542	Jul 08 07:01 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Jun 23	Sale	409.41	1,531	626,807	4,591	Jun 25 06:45 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Jun 23	Sale	409.37	1,531	626,750	75,939	Jun 25 06:45 PM
AUGUSTINOS NICHOLAS	Director	Jun 15	Sale	366.65	1,875	687,463	15,717	Jun 17 06:01 PM
Balo Andrew K	*	Jun 15	Sale	366.47	6,522	2,390,096	45,376	Jun 17 06:01 PM
Leach Jacob Steven	EVP Chief Technology Officer	Jun 11	Sale	376.76	19,129	7,207,029	107,369	Jun 15 06:00 PM
ALTMAN STEVEN R	Director	Jun 10	Sale	385.71	2,000	771,413	46,980	Jun 12 06:54 PM
KAHN BARBARA	Director	Jun 10	Sale	380.71	7,000	2,665,001	6,879	Jun 12 06:54 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Jun 10	Sale	385.22	400	154,088	22,841	Jun 12 06:54 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Jun 09	Sale	375.36	500	187,680	29,176	Jun 10 05:50 PM
SAYER KEVIN R	President, CEO and Chairman	Jun 01	Sale	376.57	6,000	2,259,400	158,542	Jun 02 04:43 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	May 26	Sale	408.49	1,474	602,114	23,241	May 28 06:47 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	May 22	Sale	396.74	1,531	607,409	77,470	May 27 06:06 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	May 22	Sale	396.74	1,531	607,409	6,122	May 27 05:56 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	May 11	Sale	404.05	400	161,620	24,715	May 13 06:30 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	May 11	Sale	404.05	500	202,025	29,676	May 13 06:16 PM
SAYER KEVIN R	President, CEO and Chairman	May 04	Sale	344.63	6,000	2,067,761	164,542	May 06 08:34 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Apr 23	Sale	318.57	1,530	487,412	7,653	Apr 27 05:00 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Apr 23	Sale	318.57	1,531	487,731	79,001	Apr 27 04:51 PM
Balo Andrew K	*	Apr 15	Sale	283.39	6,690	1,895,895	51,898	Apr 17 06:04 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Apr 13	Sale	279.88	400	111,952	25,394	Apr 15 05:18 PM
Murphy Patrick Michael	EVP, Chief Legal Officer	Apr 09	Sale	259.95	500	129,975	30,176	Apr 13 06:44 PM
SAYER KEVIN R	President, CEO and Chairman	Apr 07	Sale	262.81	6,000	1,576,839	170,542	Apr 08 06:10 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Mar 30	Sale	271.79	1,214	329,950	25,794	Apr 01 05:37 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Mar 23	Sale	209.23	1,531	320,335	80,532	Mar 25 06:22 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Mar 23	Sale	209.27	1,531	320,396	9,183	Mar 25 06:10 PM
Blackford Quentin S.	Chief Operating Officer & CFO	Mar 12	Sale	233.55	6,353	1,483,724	69,203	Mar 13 09:17 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Mar 11	Sale	264.70	3,387	896,528	27,008	Mar 13 09:20 PM
SAYER KEVIN R	President, CEO and Chairman	Mar 11	Sale	264.82	20,374	5,395,432	190,016	Mar 13 09:17 PM
Balo Andrew K	*	Mar 11	Sale	264.82	8,161	2,161,231	58,588	Mar 13 09:29 PM
Abbey Donald	EVP Quality and Regulatory Aff	Mar 11	Sale	264.68	8,050	2,130,657	69,707	Mar 13 09:28 PM
ACE HEATHER S	SVP Human Resources	Mar 11	Sale	264.69	6,207	1,642,902	38,584	Mar 13 09:28 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Mar 11	Sale	264.74	8,303	2,198,160	52,005	Mar 13 09:36 PM
Blackford Quentin S.	Chief Operating Officer & CFO	Mar 11	Sale	264.78	6,208	1,643,725	75,556	Mar 13 09:17 PM
MOY JEFFREY	EVP Operations	Mar 11	Sale	264.76	6,203	1,642,289	31,397	Mar 13 09:17 PM
Sylvain Jereme M	SVP, Finance & CAO	Mar 11	Sale	264.83	613	162,340	13,417	Mar 13 09:17 PM
Leach Jacob Steven	EVP Chief Technology Officer	Mar 11	Sale	264.69	6,909	1,828,756	127,498	Mar 13 09:17 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Mar 11	Sale	264.82	8,049	2,131,534	84,313	Mar 13 09:11 PM
Murphy Patrick Michael	*	Mar 11	Sale	264.77	4,082	1,080,794	30,676	Mar 13 09:07 PM
ACE HEATHER S	SVP Human Resources	Mar 09	Sale	269.75	7,885	2,126,955	44,791	Mar 10 08:56 PM
Selvaraj Shelly Ramasamy	SVP Information Technology	Mar 09	Sale	261.00	439	114,579	30,395	Mar 10 08:29 PM
Murphy Patrick Michael	*	Mar 09	Sale	261.00	500	130,500	34,758	Mar 10 06:49 PM
Blackford Quentin S.	Chief Operating Officer & CFO	Mar 09	Sale	261.00	891	232,551	81,764	Mar 10 08:19 PM
SAYER KEVIN R	President, CEO and Chairman	Mar 09	Sale	269.02	6,000	1,614,099	210,390	Mar 10 07:34 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Mar 05	Option Exercise	9.80	8,927	87,485	83,551	Mar 09 05:11 PM
FOLETTA MARK G	Director	Mar 03	Sale	277.08	1,000	277,079	13,147	Mar 04 06:42 PM
MOY JEFFREY	EVP Operations	Mar 02	Sale	278.10	362	100,672	25,032	Mar 03 08:15 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Feb 24	Sale	277.75	1,532	425,507	10,714	Feb 26 04:31 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Feb 24	Sale	277.81	1,531	425,323	74,624	Feb 26 04:24 PM
Leach Jacob Steven	EVP Chief Technology Officer	Feb 18	Option Exercise	9.78	11,458	112,059	122,563	Feb 19 07:53 PM
MOY JEFFREY	EVP Operations	Feb 18	Sale	286.91	6,599	1,893,318	25,220	Feb 20 06:23 PM
Collins Richard Alexander	Director	Feb 18	Sale	284.40	4,000	1,137,600	5,304	Feb 20 06:17 PM
AUGUSTINOS NICHOLAS	Director	Feb 14	Sale	283.80	1,812	514,246	3,230	Feb 18 06:58 PM
Murphy Patrick Michael	SVP, Legal Affairs	Feb 10	Sale	240.59	500	120,295	26,447	Feb 11 07:53 PM
SAYER KEVIN R	President, CEO and Chairman	Feb 10	Sale	242.39	6,000	1,454,367	190,937	Feb 11 07:48 PM
FOLETTA MARK G	Director	Feb 03	Sale	237.84	1,000	237,843	14,147	Feb 05 06:04 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Jan 23	Sale	234.34	1,532	359,003	12,246	Jan 27 05:13 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Jan 23	Sale	234.32	1,532	358,971	76,155	Jan 27 05:06 PM
SAYER KEVIN R	President, CEO and Chairman	Jan 13	Sale	230.62	6,000	1,383,710	196,937	Jan 15 04:48 PM
Murphy Patrick Michael	SVP, Legal Affairs	Jan 09	Sale	235.01	500	117,505	26,947	Jan 10 08:03 PM
FOLETTA MARK G	Director	Jan 03	Sale	218.05	1,000	218,053	15,147	Jan 07 08:49 PM
SKYLER JAY S	Director	Jan 03	Sale	217.85	25,806	5,621,816	30,417	Jan 07 08:50 PM
ALTMAN STEVEN R	Director	Jan 02	Sale	218.33	2,500	545,834	46,304	Jan 06 09:05 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Dec 23	Sale	213.17	1,532	326,576	77,687	Dec 23 07:42 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Dec 23	Sale	213.02	1,533	326,558	13,778	Dec 23 07:42 PM
AUGUSTINOS NICHOLAS	Director	Dec 16	Sale	206.14	1,812	373,526	5,042	Dec 16 09:17 PM
KAHN BARBARA	Director	Dec 12	Sale	205.14	9,000	1,846,222	11,266	Dec 16 09:16 PM
Murphy Patrick Michael	SVP, Legal Affairs	Dec 09	Sale	224.42	5,518	1,238,346	27,447	Dec 10 08:42 PM
FOLETTA MARK G	Director	Dec 03	Sale	227.59	1,000	227,593	16,147	Dec 05 04:22 PM
SAYER KEVIN R	President, CEO and Chairman	Dec 02	Sale	221.37	10,000	2,213,684	202,937	Dec 04 08:04 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Nov 22	Sale	217.56	1,533	333,519	15,311	Nov 25 07:43 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Nov 22	Sale	217.56	1,532	333,300	79,219	Nov 25 07:42 PM
Abbey Donald	EVP Quality and Regulatory Aff	Nov 21	Sale	220.21	11,604	2,555,329	68,946	Nov 25 06:20 PM
AUGUSTINOS NICHOLAS	Director	Nov 07	Sale	185.29	1,208	223,830	6,854	Nov 08 08:58 PM
SAYER KEVIN R	President, CEO and Chairman	Nov 04	Sale	157.50	10,000	1,575,017	212,937	Nov 06 06:20 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Oct 23	Sale	152.37	1,532	233,435	80,751	Oct 25 04:35 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Oct 23	Sale	152.34	1,533	233,530	16,844	Oct 25 04:35 PM
SAYER KEVIN R	President, CEO and Chairman	Oct 01	Sale	149.60	10,000	1,496,001	222,937	Oct 03 06:40 PM
ALTMAN STEVEN R	Director	Oct 01	Sale	149.17	2,500	372,916	48,804	Oct 03 06:40 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Sep 24	Sale	155.00	2,016	312,482	0	Sep 26 08:42 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Sep 23	Sale	155.47	1,532	238,181	82,283	Sep 25 07:37 PM
Balo Andrew K	*	Sep 18	Sale	151.46	2,386	361,384	57,916	Sep 19 06:46 PM
AUGUSTINOS NICHOLAS	Director	Sep 16	Sale	145.49	1,208	175,752	8,062	Sep 18 06:03 PM
Blackford Quentin S.	EVP Chief Financial Officer	Sep 10	Sale	141.25	10,320	1,457,691	69,754	Sep 12 04:25 PM
Leach Jacob Steven	EVP Chief Technology Officer	Sep 09	Sale	149.86	4,712	706,118	111,105	Sep 11 09:29 PM
Abbey Donald	EVP Quality and Regulatory Aff	Sep 09	Sale	149.85	5,843	875,598	80,550	Sep 11 09:30 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Sep 09	Sale	149.85	5,843	875,594	66,821	Sep 11 09:28 PM
Murphy Patrick Michael	SVP Legal Affairs	Sep 09	Sale	149.86	2,495	373,897	32,965	Sep 11 09:28 PM
Pacelli Steven Robert	EVP Strategy and Corporate Dev	Sep 09	Sale	149.86	5,843	875,620	83,815	Sep 11 09:29 PM
SAYER KEVIN R	President, CEO and Chairman	Sep 09	Sale	149.86	14,322	2,146,269	232,937	Sep 11 09:27 PM
MOY JEFFREY	SVP Operations	Sep 09	Sale	149.85	4,601	689,475	34,869	Sep 11 09:45 PM
Balo Andrew K	*	Sep 09	Sale	151.56	9,107	1,380,234	60,302	Sep 11 09:42 PM
Blackford Quentin S.	EVP Chief Financial Officer	Sep 09	Sale	149.86	11,686	1,751,232	80,074	Sep 11 09:36 PM
ACE HEATHER S	SVP Human Resources	Sep 09	Sale	151.22	6,415	970,073	52,676	Sep 11 09:32 PM
SAYER KEVIN R	President, CEO and Chairman	Sep 03	Sale	170.13	10,000	1,701,274	247,259	Sep 05 04:16 PM
Balo Andrew K	*	Sep 03	Sale	170.00	37	6,290	69,409	Sep 05 04:16 PM
ACE HEATHER S	SVP Human Resources	Aug 23	Sale	174.80	7,243	1,266,062	59,091	Aug 26 09:12 PM
DOUBLEDAY RICHARD	EVP Chief Commercial Officer	Aug 23	Sale	175.14	2,016	353,088	2,016	Aug 26 09:12 PM
SAYER KEVIN R	President, CEO and Chairman	Aug 15	Sale	156.12	10,000	1,561,167	278,100	Aug 19 06:20 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience